Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Handler

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Proteomes|August 23, 2020
PeptideWitch-A Software Package to Produce High-Stringency Proteomics Data Visualizations from Label-Free Shotgun Proteomics DataDavid C L Handler, Flora Cheng, Abdulrahman M Shathili, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 6, 2020
Comparison of protein and peptide fractionation approaches in protein identification and quantification from Saccharomyces cerevisiaeLiting Deng, David C L Handler, Dylan H Multari, et al.
Journal of Personality Assessment|July 6, 2000
A replication of Rorschach and MMPI-2 convergent validityG J Meyer, R J Riethmiller, R D Brooks, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 17, 1990
Extradural spinal myeloma and emergency neurosurgeryP Jacobs, H S King, I Le Roux, et al.
Pediatrics|March 4, 2016
A Multifaceted Approach to Improving Outcomes in the NICU: The Pediatrix 100 000 Babies CampaignDan L Ellsbury, Reese H Clark, Robert Ursprung, et al.
The Journal of Investigative Dermatology|January 1, 1993
Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zoneP Contard, R L Bartel, L Jacobs, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Proteomes|August 23, 2020
PeptideWitch-A Software Package to Produce High-Stringency Proteomics Data Visualizations from Label-Free Shotgun Proteomics DataDavid C L Handler, Flora Cheng, Abdulrahman M Shathili, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|December 6, 2020
Comparison of protein and peptide fractionation approaches in protein identification and quantification from Saccharomyces cerevisiaeLiting Deng, David C L Handler, Dylan H Multari, et al.
Journal of Personality Assessment|July 6, 2000
A replication of Rorschach and MMPI-2 convergent validityG J Meyer, R J Riethmiller, R D Brooks, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|March 17, 1990
Extradural spinal myeloma and emergency neurosurgeryP Jacobs, H S King, I Le Roux, et al.
Pediatrics|March 4, 2016
A Multifaceted Approach to Improving Outcomes in the NICU: The Pediatrix 100 000 Babies CampaignDan L Ellsbury, Reese H Clark, Robert Ursprung, et al.
The Journal of Investigative Dermatology|January 1, 1993
Culturing keratinocytes and fibroblasts in a three-dimensional mesh results in epidermal differentiation and formation of a basal lamina-anchoring zoneP Contard, R L Bartel, L Jacobs, et al.
Scientific Reports|December 23, 2017
Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple MyelomaAllison E Drew, Oscar Moradei, Suzanne L Jacques, et al.
Nature Cancer|November 18, 2021
Discovery of a first-in-class reversible DNMT1-selective inhibitor with improved tolerability and efficacy in acute myeloid leukemiaMelissa B Pappalardi, Kathryn Keenan, Mark Cockerill, et al.
Pageof 5